RIULSRepository of Iași University of Life Sciences, ROMANIA

Preliminary data regarding dogs as WNV sentinels

Show simple item record

dc.contributor.author Ludu Oșlobanu, Luanda-Elena
dc.contributor.author Buzdugan, Ioana
dc.contributor.author Crivei, Luciana-Alexandra
dc.contributor.author Dascălu, Mihaela-Anca
dc.contributor.author Cozma, Andreea-Paula
dc.contributor.author Savuța, Gheorghe
dc.contributor.author Marot, Stephane
dc.contributor.author Moroșan, Șerban
dc.date.accessioned 2025-07-09T07:03:53Z
dc.date.available 2025-07-09T07:03:53Z
dc.date.issued 2024
dc.identifier.citation Oșlobanu, Luanda Elena, Ioana Buzdugan, Luciana Crivei, Anca Dascălu, Andreea Cozma, Savuța Gheorghe, Stephane Marot, Șerban Moroșan. 2024. “Preliminary data regarding dogs as WNV sentinels”. Lucrări Științifice IULS Seria Medicină Veterinară 67 (4): 75-78. https://doi.org/10.61900/SPJVS.2024.04.13 en_US
dc.identifier.issn 1454-7406
dc.identifier.uri https://repository.iuls.ro/xmlui/handle/20.500.12811/5450
dc.description.abstract West Nile Virus (WNV) is a mosquito-borne flavivirus that has a zoonotic character determining an inapparent infection, mild unspecific symptoms as flu like manifestations or a severe encephalitis, and can also affect other mammals, including dogs. Most dogs exposed to WNV exhibit mild symptoms such transient fever, lethargy, or loss of appetite. Severe neurological manifestations, including ataxia, seizures, and paralysis, are rare but can occur in immunocompromised or highly exposed animals. The role of dogs as amplifying hosts is minimal due to low-level viremia. However, despite the relatively low risk to dogs, the presence of WNV in canine populations reflects broader environmental and public health concerns, as it can serve as a marker for potential human exposure. This preliminary study aimed to verify the hypothesis of dogs as indicators of WNV evolution. Samples collected in 2023 and 2022 from a public dog shelter and a veterinary private clinic from Iasi County were tested for the presence of specific anti WNV antibodies. The results showed and overall prevalence of 37,5% [(IC 95% (27.38 - 47.62)] in the dog samples collected from the dog shelter and a 18,4% [(IC 95% (10.96-25.94)] in the samples collected from the private practice. Those are in accordance with the epidemiological situation in humans in 2023 and 2022 in the County. The study is preliminary and intend to add data to the international research. Further analyses are needed to clarify if dogs can be considered sentinels for WNV infection in humans. en_US
dc.language.iso en en_US
dc.publisher Publishing “Ion Ionescu de la Brad”, Iași en_US
dc.rights Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subject WNV en_US
dc.subject sentinel en_US
dc.subject dogs en_US
dc.subject seroprevalence en_US
dc.subject preliminary data en_US
dc.title Preliminary data regarding dogs as WNV sentinels en_US
dc.type Article en_US
dc.author.affiliation Luanda Elena Oșlobanu, Ioana Buzdugan, Luciana Crivei, Anca Dascălu, Andreea Cozma, Savuța Gheorghe, Șerban Moroșan, “Ion Ionescu de la Brad” Iasi University of Life Sciences, Public Health Department, Romania
dc.author.affiliation Stephane Marot, Sorbonne University, INSERM, UMS 28, France
dc.author.affiliation Șerban Moroșan, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France
dc.publicationName Lucrări Științifice IULS Seria Medicină Veterinară
dc.volume 67
dc.issue 4
dc.publicationDate 2024
dc.startingPage 75
dc.endingPage 78
dc.identifier.eissn 2393-4603
dc.identifier.doi 10.61900/SPJVS.2024.04.13


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)